FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation

被引:0
|
作者
Tomiyasu, Haruki [1 ]
Habara, Makoto [1 ]
Hanaki, Shunsuke [1 ]
Sato, Yuki [1 ]
Miki, Yousei [1 ]
Shimada, Midori [2 ]
机构
[1] Yamaguchi Univ, Fac Vet Sci, Dept Vet Biochem, Yamaguchi, Japan
[2] Nagoya Univ, Mol Biol, Grad Sch Med, Nagoya, Aichi, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-1024
引用
收藏
页码:232 / 232
页数:1
相关论文
共 50 条
  • [41] SUMO-specific protease 2 in Mdm2-mediated regulation of p53
    M Jiang
    S-Y Chiu
    W Hsu
    Cell Death & Differentiation, 2011, 18 : 1005 - 1015
  • [42] CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway
    Xu, Ming
    Tang, Jie
    Sun, Qiong
    Meng, Jing
    Chen, Guoyu
    Chang, Yunli
    Yao, Yao
    Ji, Jieru
    Luo, Hao
    Chen, Lingling
    Lu, Minxue
    Shi, Weiwei
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (05) : 1655 - 1671
  • [43] Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53
    Chen, Yunzhao
    Xin, Huahua
    Peng, Hao
    Shi, Qi
    Li, Menglu
    Yu, Jie
    Tian, Yanxia
    Han, Xueping
    Chen, Xi
    Zheng, Yi
    Li, Jun
    Yang, Zhihao
    Yang, Lan
    Hu, Jianming
    Huang, Xuan
    Liu, Zheng
    Huang, Xiaoxi
    Zhou, Hong
    Cui, Xiaobin
    Li, Feng
    CANCER RESEARCH, 2020, 80 (11) : 2175 - 2189
  • [44] Cancer gene therapy with a modified p53 overcomes mdm2-mediated oncogenic transformation.
    Page, C
    Lin, HJ
    Sondak, V
    Jiang, GH
    Castle, V
    Changery, J
    Reynolds, K
    Lin, JY
    CLINICAL CANCER RESEARCH, 1999, 5 : 3758S - 3758S
  • [45] TRIM67 PREVENTS COLORECTALTUMORIGENESIS IN MICE BY INTERACTING WITH P53 TO PREVENT MDM2-MEDIATED DEGRADATION
    Wang, Shiyan
    Zhang, Yanquan
    Huang, Junzhe
    Wong, Chi Chun
    Zhai, Jianning
    Li, Chuangen
    Wei, Guifeng
    Zhao, Liuyang
    Wang, Guoping
    Wei, Hong
    Sung, Joseph J.
    Yu, Jun
    GASTROENTEROLOGY, 2019, 156 (06) : S95 - S95
  • [46] Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradation
    Zhang, Zhuo
    Zhang, Ruiwen
    EMBO JOURNAL, 2008, 27 (06): : 852 - 864
  • [47] Identification of p53 sequence elements that are required for MDM2-mediated nuclear export
    Gu, JJ
    Nie, LH
    Wiederschain, D
    Yuan, ZM
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (24) : 8533 - 8546
  • [48] Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
    Katayama, H
    Sasai, K
    Kawai, H
    Yuan, ZM
    Bondaruk, J
    Suzuki, F
    Fujii, S
    Arlinghaus, RB
    Czerniak, BA
    Sen, S
    NATURE GENETICS, 2004, 36 (01) : 55 - 62
  • [49] MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53
    Wang, Yu-Sheng
    Yin, Ji-Zhong
    Shi, Xiao-Qian
    Zhao, Xue-Wei
    Li, Bing
    Yang, Meng-Hang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (16) : 1829 - 1837
  • [50] ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
    Ning, Yichong
    Hui, Na
    Qing, Bei
    Zhuo, Yiming
    Sun, Wei
    Du, Yan
    Liu, Shunlian
    Liu, Kaili
    Zhou, Jianlin
    CELL DEATH & DISEASE, 2019, 10 (6)